Retinoic acid suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma

British Journal of Dermatology

Volumn 152, Issue 3, 2005, Pages 435-443

  Kunisada, Makoto ^a   Budiyanto, A ^a   Bito, T ^a   Nishigori, C ^a   Ueda, M ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Akt; All trans retinoic acid; ERK1 2; hTERT protein

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MYC PROTEIN; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; RETINOIC ACID; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1;

ARTICLE; CANCER GROWTH; CARCINOMA CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; REGULATORY MECHANISM; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL DIVISION; DNA-BINDING PROTEINS; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; NEOPLASM PROTEINS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SKIN NEOPLASMS; TELOMERASE; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 17444418633     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06471x     Document Type: Article

References (44)

1. Fisher GJ, Voorhees JJ. Molecular mechanisms of retinoid actions in skin. FASEB J 1996; 10:1002-13.
2. Elias PM, Fritsch PO, Lampe M et al. Retinoid effects on epidermal structure, differentiation and permeability. Lab Invest 1981; 44:531-40.
3. Lippman SM, Lotan R. Advances in the development of retinoids as chemopreventive agents. J Nutr 2000; 130 (Suppl.): 479S-82S.
4. Soprano KJ, Soprano DR. Retinoic acid receptors and cancer. J Nutr 2002; 132 (Suppl.): 3809S-13S.
5. Kiyono T, Foster SA, Koop JI et al. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 1998; 396:84-8.
6. Ueda M, Ouhtit A, Bito T et al. Evidence for UV-associated activation of telomerase in human skin. Cancer Res 1997; 57:370-4.
7. Wu A, Ichihashi M, Ueda M. Correlation of the expression of human telomerase subunits with telomerase activity in normal skin and skin tumors. Cancer 1999; 86:2038-44.
8. Budiyanto A, Bito T, Kunisada M et al. Inhibition of the EGF receptor suppresses telomerase activity in HCS-1 human cutaneous squamous cell carcinoma cells. J Invest Dermatol 2003; 121:1088-94.
9. Mano Y, Shimizu T, Tamura S, Takeda K. Synergistic down-regulation of telomerase activity and hTERT mRNA expression by combination of retinoic acid and GM-CSF in human myeloblastic leukemia ML-1 cells. Anticancer Res 2000; 30:1649-52.
10. Pendino F, Flexor M, Delhommeau F et al. Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation. Proc Natl Acad Sci USA 2001; 98:6662-7.
11. Choi SH, Kang HK, Im EO et al. Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by retinoic acids. Int J Oncol 2000; 17:971-6.
12. Ding Z, Green AG, Yang X et al. Retinoic acid inhibits telomerase activity and downregulates expression but does not affect splicing of hTERT: correlation with cell growth rate inhibition in an in vitro cervical carcinogenesis/multidrug-resistance model. Exp Cell Res 2002; 272:185-91.
13. Rubin Grandis J, Zeng Q, Tweardy DJ. Retinoic acid normalizes the increased gene transcription rate of TGF-α and EGFR in head and neck cancer cell lines. Nat Med 1996; 2:237-40.
14. Sah JF, Eckert RL, Chandraratna RAS, Rorke EA. Retinoids suppress epidermal growth factor-associated cell proliferation by inhibiting epidermal growth factor receptor-dependent ERK1/2 activation. J Biol Chem 2002; 277:9728-35.
15. Kondo S, Aso K. Establishment of a cell line of human skin squamous cell carcinoma in vitro. Br J Dermatol 1981; 105:125-32.
16. Hayashi K, Yokozaki H, Naka K et al. Effect of 9-cis-retinoic acid on oral squamous cell carcinoma cell lines. Cancer Lett 2000; 151:199-208.
17. Wanner R, Wolff B, Glowacki F et al. The loss of desmosomes after retinoic acid treatment results in an apparent inhibition of HaCaT keratinocyte differentiation. Arch Dermatol Res 1999; 291:346-53.
18. Kyo S, Takakura M, Taira T et al. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res 2000; 28:669-77.
19. Takakura M, Kyo S, Kanaya T et al. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res 1999; 59:551-7.
20. Horikawa I, Cable PL, Afshari C, Barren JC. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res 1999; 59:826-30.
21. Wu K-J, Grandori C, Amacker M et al. Direct activation of TERT transcription by c-Myc. Nat Gen 1999; 21:220-4.
22. Maida Y, Kyo S, Kanaya T et al. Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway. Oncogene 2002; 21:4701-9.
23. Günes Ç, Lichtsteiner S, Vasserot AP, Englert C. Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1. Cancer Res 2000; 60:21 16-21.
24. Oh S, Song Y-H, Yim J, Kim TK. Identification of Mad as a repressor of the human telomerase (hTERT) gene. Oncogene 2000; 19:1485-90.
25. Kyo S, Takakura M, Kanaya T et al. Estrogen activates telomerase. Cancer Res 1999; 59:5917-21.
26. Wang Z, Kyo S, Takakura M et al. Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathway. Cancer Res 2000; 60:5376-81.
27. Inui T, Shinomiya N, Fukasawa M et al. Growth-related signaling regulates activation of telomerase in regenerating hepatocytes. Exp Cell Res 2002; 273:147-56.
28. Kyo S, Inoue M. Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy? Oncogene 2002; 21:688-97.
29. You YO, Lee G, Min BM. Retinoic acid extends the in vitro life span of normal human oral keratinocytes by decreasing p16 (INK4A) expression and maintaining telomerase activity. Biochem Biophys Res Commun 2000; 16:268-74.
30. Holt SE, Wright WE, Shay JW. Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 1996; 16:2932-9.
31. Zhu X, Kumar R, Mandal M et al. Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc Natl Acad Sci USA 1996; 93:6091-5.
32. Akiyama M, Hideshima T, Hayashi T et al. Cytokines modulate telomerase activity in a human multiple myeloma cell line. Cancer Res 2002; 62:3876-82.
33. Breitschopf K, Zeiher AM, Dimmeler S. Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism. FEBS Lett 2001; 493:21-5.
34. Watterau LA, Francis MJ, Ma L, Cohen P. Insulin-like growth factor I stimulates telomerase activity in prostate cancer cells. J Clin Endocrinol Metab 2003; 88:3354-9.
35. Gianni M, Kopf E, Bastien J et al. Down-regulation of the phosphatidylinositol 3-kinase/Akt pathway is involved in retinoic acid-induced phosphorylation, degradation, and transcriptional activity of retinoic acid receptor γ2. J Biol 2002; 277:24859-62.
36. WAF1 gene expression. Mol Carcinog 1998; 21:26-36.
37. Harada K, Kurisu K, Sadatomo T et al. Growth inhibition of human glioma cells by transfection-induced p21 and its effects on telomerase activity. J Neurooncol 2000; 47:39-46.
38. Fuxe J, Akusjarvi G, Goike HM et al. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A. Cell Growth Differ 2000; 11:373-84.
39. CIP1 and inhibition of expression of cyclin D1. Cancer Res 2002; 62:3997-4006.
40. Baldassarre G, Boccia A, Bruni P et al. Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27. Cell Growth Differ 2000; 11:517-26.
41. Hatoum A, El-Sabban ME, Khoury J et al. Overexpression of retinoic receptors alpha and gamma into neoplastic epidermal cells causes retinoic acid-induced growth arrest and apoptosis. Carcinogenesis 2001; 22:1955-63.
42. Zouboulis CC, Seltmann H, Oliver Sass J et al. Retinoid signaling by all-trans retinoic acid and all-trans retinoyl-β-D-glucuronide is attenuated by simultaneous exposure of human keratinocytes to retinol. J Invest Dermatol 1999; 112:157-64.
43. Darwiche N, Celli G, Tennenbaum T et al. Mouse skin tumor progression results in differential expression of retinoic acid and retinoid X receptors. Cancer Res 1995; 55:2774-82.
44. Xu X-C, Wong WYL, Goldberg L et al. Progressive decrease in nuclear retinoid receptors during skin squamous carcinogenesis. Cancer Res 2001; 61:4306-10.